http://www.fpnotebook.com/
Leukotriene Receptor Antagonist
Aka: Leukotriene Receptor Antagonist, Leukotriene Synthesis Inhibitor, Accolate, Zafirlukast, Montelukast, Singulair, Zileuton, Zyflo
- Preparations
- Zafirlukast (Accolate)
- Montelukast (Singulair)
- Zileuton (Zyflo)
- Mechanism
- Attenuates bronchoconstriction and inflammation
- Leukotriene Receptor Antagonists
- Zafirlukast (Accolate)
- Montelukast (Singulair)
- Leukotriene Synthesis Inhibitor
- Zileuton (Zyflo)
- Indication: Adjunctive in Asthma and Allergic Rhinitis
- Moderate Persistent Asthma
- Severe Persistent Asthma
- Moderate Chronic Obstructive Pulmonary Disease
- Aspirin-induced Asthma
- Exercise-Induced Bronchospasm
- Allergic Rhinitis
- Dosing: Zafirlukast (Accolate)
- Leukotriene Receptor Antagonist
- Avoid at mealtime
- Take 1 hour before or 2 hours after meals
- Dose
- Age >11 years old: 20 mg PO bid
- Child 7-11 years old: 10 mg PO bid
- Dosing: Montelukast (Singulair)
- Leukotriene Receptor Antagonist
- Dose
- Adults: 10 mg PO qhs
- Child age 6 to 14 years: 5 mg PO qhs
- Child age 2-5 years: 4 mg PO qhs
- Dosing: Zileuton (Zyflo)
- Leukotriene Synthesis Inhibitor
- Indicated in age only 12 and over
- Dose: 600 mg orally four times daily
- Hepatotoxicity in 5% (Monitor liver enzymes q3 months)
- Drug interactions: Warfarin, theophylline, Propranolol
- Expensive ($273 per month)
- Efficacy
- Modestly effective for maintenance management
- Inhaled Steroids are preferred over leukotriene agents
- Used as adjunctive therapy in Asthma
- Benefit may be limited to patients with the 5-LO and LTC4 polymorphisms
- Sampson (2004) RT J Respir Care Practitioners 17:30-2
- Wechsler (2005) Am J Respir Crit Care Med 172(1): 12-8
- Adverse Effects
- Multiple P450 drug interactions
- Potentiates Warfarin
- Potentiates Theophylline
- Potentiates Propranolol
- Some association with Churg-Strauss Syndrome
- Systemic Eosinophilic Vasculitis
- Vasculitic rash
- Pulmonary and cardiac conditions
- Hepatotoxicity with Zileuton (Zyflo)
- Cost
- Among most expensive agents in Asthma
- Accolate and Singulair: $90-100 per month
- Zyflo: $270 per month
- References
- (1996) Med Lett Drugs Ther 38:111-2
- (2000) Med Lett Drugs Ther 42:22-3
- Scow (2007) Am Fam Physician 75:65-70
- Wilson (2001) Chest 119:2021-6